Pharmacokinetics and metabolomics of the new psychoactive substance 4-chloroethylcathinone

Yong Wang,Ying Yang,Yujuan Zhan,Jun Yin,Xueting Zhou,Chen Xu,Feiyu Gao,Junning Liu,Chunyong Wu,Songqin Liu,Junying Zhang,Chang Shu
DOI: https://doi.org/10.1016/j.arabjc.2023.105039
IF: 6.212
2023-06-10
Arabian Journal of Chemistry
Abstract:Synthetic 4-Chloroethcathinone (4-CEC) is a derivative of cathinone that belongs to one of the more severe abused substances among new psychoactive substances (NPS). Current researches on 4-CEC mainly focus on metabolite identification studies, and there is a lack of researches on pharmacokinetic, tissue distribution and metabolomics studies in vivo . A sensitive and reliable LC-MS/MS assay was developed and validated for the determination of 4-CEC concentrations in plasma and tissue homogenates. According to the pharmacokinetic results, the absorption and elimination of 4-CEC were faster after administration. The C max was 1896 ± 876 ng/ml, the peak time T max was 10.1 ± 9.2 min, and the elimination half-life t 1/2 was 100.4 min. Metabolomics studies showed that the highest concentrations of 4-CEC were found in brain, lung, kidney and liver. The results of tissue biopsy showed that the liver, kidney and brain tissue had a certain degree of damage. After 4-CEC administration, amino acid-related metabolism and biosynthesis, lipid metabolism, niacin and niacinamide metabolism in mice were interfered, suggesting that 4-CEC could cause energy metabolism disorder in mice. The metabolic pathways and toxicity mechanisms related to 4-CEC entry into the body were explained at the overall metabolic level by multivariate data analysis, screening and identification of differential metabolites and metabolic pathway analysis.
chemistry, multidisciplinary
What problem does this paper attempt to address?